Translational Development Acquisition (TDACW) Treasury Shares (2023 - 2026)

Translational Development Acquisition (TDACW) has reported Treasury Shares for 4 consecutive years, with $14.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Treasury Shares fell 15.06% year-over-year to $14.7 million; the trailing twelve-month figure through Jun 2026 stood at $14.7 million (down 15.06% YoY), and the FY2025 full-year result was $17.2 million, changed 0.0% from the prior year.
• Treasury Shares slipped to $14.7 million in Q2 2026 per TDACW's latest filing, from $17.2 million in the prior quarter.
• Across five years, Treasury Shares topped out at $17.2 million in Q4 2023 and bottomed at $14.7 million in Q2 2026.
• Historically, Treasury Shares has averaged $16.9 million across 4 years, with a median of $17.2 million in 2023.
• The sharpest annual moves came in 2024 and 2026: Treasury Shares changed 0.0% in 2024, then declined 15.06% in 2026.
• Over 4 years, Treasury Shares stood at $17.2 million in 2023, then changed by 0.0% to $17.2 million in 2024, then changed by 0.0% to $17.2 million in 2025, then decreased by 15.06% to $14.7 million in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $14.7 million, $17.2 million, and $17.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.